PGP and colorectal carcinoma: Then in CRC, SYMD2 regulated P-gp expression by activating the Mitogen-activated protein kinase (MEK)/Extracellular signal-regulated kinase (ERK)/activator protein 1 (AP-1) signalling pathway, promoting oxaliplatin resistance (Ren et al., 2019).